| pubmed-article:17577932 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0018133 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0600554 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:17577932 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:17577932 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17577932 | pubmed:dateCreated | 2007-6-19 | lld:pubmed |
| pubmed-article:17577932 | pubmed:abstractText | Limited clinical trials have validated the hypothesis of controlling graft-versus-host disease (GVHD) arising from stem cell transplant utilizing suicidal T-lymphocytes that have been transduced to express the HSV-TK gene. However, clinical utility has been limited by diminished T-cell function arising from the production process. To evaluate strategies for harnessing the graft-versus-leukemia (GVL) effect while improving the safety and function of suicidal lymphocytes, we have developed techniques to produce fully functional, retrovirally transduced, HSV-TK-positive murine T cells (TK+TC). | lld:pubmed |
| pubmed-article:17577932 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577932 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17577932 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577932 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17577932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577932 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17577932 | pubmed:month | May | lld:pubmed |
| pubmed-article:17577932 | pubmed:issn | 0301-472X | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:ChamplinRicha... | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:KornblauSteve... | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:MariniFrank... | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:StephensClift... | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:AycoxPreston... | lld:pubmed |
| pubmed-article:17577932 | pubmed:author | pubmed-author:McCueL... | lld:pubmed |
| pubmed-article:17577932 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17577932 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:17577932 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17577932 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17577932 | pubmed:pagination | 842-53 | lld:pubmed |
| pubmed-article:17577932 | pubmed:dateRevised | 2007-12-3 | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:meshHeading | pubmed-meshheading:17577932... | lld:pubmed |
| pubmed-article:17577932 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17577932 | pubmed:articleTitle | Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes. | lld:pubmed |
| pubmed-article:17577932 | pubmed:affiliation | Department of Blood and Marrow Transplantation, Unit 448, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009, USA. skornbla@mdanderson.org | lld:pubmed |
| pubmed-article:17577932 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17577932 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17577932 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577932 | lld:pubmed |
